LEXXEL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Lexxel, and what generic alternatives are available?

Lexxel is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in LEXXEL is enalapril maleate; felodipine. There are twenty-seven drug master file entries for this compound. Additional details are available on the enalapril maleate; felodipine profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LEXXEL?
What are the global sales for LEXXEL?
What is Average Wholesale Price for LEXXEL?

Summary for LEXXEL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	55
Formulation / Manufacturing:	see details
DailyMed Link:	LEXXEL at DailyMed

Drug patent expirations by year for LEXXEL

US Patents and Regulatory Information for LEXXEL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-002	Oct 28, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-001	Dec 27, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LEXXEL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-002	Oct 28, 1998	⤷ Sign Up	⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-001	Dec 27, 1996	⤷ Sign Up	⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-002	Oct 28, 1998	⤷ Sign Up	⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-001	Dec 27, 1996	⤷ Sign Up	⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-002	Oct 28, 1998	⤷ Sign Up	⤷ Sign Up
Astrazeneca	LEXXEL	enalapril maleate; felodipine	TABLET, EXTENDED RELEASE;ORAL	020668-002	Oct 28, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LEXXEL

See the table below for patents covering LEXXEL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Bosnia and Herzegovina	98220		⤷ Sign Up
Portugal	81308	PROCESS FOR PREPARING A COMBINATION OF DIHYDROPYRIDINES WITH ACE(ANGIOTENSIN CONVERTING ENZYMES) INHIBITORS USEFUL AS MEDICAMENT	⤷ Sign Up
Australia	4831679		⤷ Sign Up
Philippines	24268	PROCESS FOR PREPARING AMINO ACID DERIVATIVES	⤷ Sign Up
U.S.S.R.	1743332	CПOCOБ ПOЛУЧEHИЯ TAБЛETOK (PROCESS FOR PRODUCING TABLETS)	⤷ Sign Up
Denmark	165455		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for LEXXEL

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0007293	95C0001	Belgium	⤷ Sign Up	PRODUCT NAME: FELODIPINE, METOPOLOL SUCCINATE; NAT. REGISTRATION NO/DATE: 122 IS 160 F 3 / 19921230; FIRST REGISTRATION: DK 8678 19921230
0007293	SPC/GB93/134	United Kingdom	⤷ Sign Up
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for LEXXEL

Make Better Decisions: Try a trial or see plans & pricing